Get started
Author

Vaishnavi Kalmegh

Observed name: Kalmegh, Vaishnavi
ORCID: 0000-0001-6849-9846
Observed ORCID: 0000-0001-6849-9846
OpenAlex ID: A5092966635
Imidazopyrimidine: from a relatively exotic scaffold to an evolving structural motif in drug discovery
2024 · Moumita Ghosh Chowdhury, Vaishnavi Kalmegh, et al. · RSC Medicinal Chemistry · 10
PDF
Rare diseases and pyruvate kinase M2: a promising therapeutic connection
2024 · Saumya Kapoor, Vaishnavi Kalmegh, et al. · Drug Discovery Today · 6
Mechanism-guided discovery of chromene-chalcone hybrids targeting PKM2 and microtubules for breast cancer therapy
2025 · Madhurendra Kumar Katiyar, Shubham Upadhayay, et al. · Bioorganic Chemistry · 5
Moonlighting Effects of Pyruvate Kinase M2 in Chronic Liver Diseases
2023 · Madhav Jadhav, Shailendra Sharma, et al. · Gene Expression · 4
PDF
Sustainable synthesis and biological evaluation of novel ferrocene derivatives as metabolic modulators of pyruvate kinase M2 in oral cancer
2026 · Vaishnavi Kalmegh, Archit Jain, et al. · Inorganic Chemistry Communications · 3
Computational Design, Chemical Synthesis, and Bioevaluation of Pyrimidinyl‐Indoles for Targeting Breast Cancer Cells
2024 · Preethi Parameswaran, Darshan Contractor, et al. · ChemistrySelect · 2
PDF
Coumarin–sulfonamide hybrids as PKM2 activators induce metabolic reprogramming and suppress ovarian cancer cell growth
2026 · Deep Rohan Chatterjee, Gourav Choudhary, et al. · Bioorganic & Medicinal Chemistry
CCDC 2519792: Experimental Crystal Structure Determination
2026 · Kalmegh, Vaishnavi, Jain, Archit, et al. · The Cambridge Structural Database
Pyruvate kinase M2 – linked metabolic pathways in pain modulation
2025 · Vaishnavi Kalmegh, Lahanya Guha, et al. · Drug Discovery Today
Works count: 9
Citation count: 30
H-index: 4
I10-index: 1
Year
Topic
Type